Project Grant R21NS140036
Award Date
12/15/24
Completion Date
11/30/26
Dollars Obligated
$240K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $324,464 to the Ann & Robert H. Lurie Children's Hospital of Chicago to characterize the early childhood neurodevelopmental impact of infants exposed to maternal SARS-CoV-2 infection during pregnancy. The key products and services to be delivered include: Conducting developmental assessments on infants born...
This $5.1 million project grant from the National Institute of Mental Health (NIMH), part of the Department of Health and Human Services, supports research under the Mental Health Research Grants program (CFDA 93.242). The Massachusetts General Hospital will utilize its existing biobank of over 800 maternal blood and neonatal cord blood samples linked to clinical records to characterize the impact of maternal SARS-CoV-2 infection on fetal neurodevelopment. Researchers will analyze immune...
This $3,305,720 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to define the impact of maternal viral infections and inflammation on immune programming within the fetal brain and lymphoid organs in a non-human primate (NHP) model. The objectives are to: 1) Determine innate immune pathways activated by model viruses, type I interferon, IL-6, and...
This $664,837 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to comprehensively screen newborns for in-utero SARS-CoV-2 infection and assess associated immune responses and clinical outcomes. The primary objectives are to: 1) Identify newborns with in-utero SARS-CoV-2 infection using a multi-faceted approach involving antibody and PCR testing of cord blood, placental...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $205,999 to support research on maternal-fetal immune responses to infectious diseases, including SARS-CoV-2 and malaria. The 5-year grant, awarded on December 4, 2024, will fund the development of a cohort of young investigators conducting translational research in perinatal infectious diseases. The research...
This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of gestational hypoxia (a characteristic of gestational sleep apnea) in maternal brain health. The $117,226 award, with a project period from March 1, 2025 to February 28, 2027, will be used by the University of North Texas Health Science Center at Fort Worth...
This federal Project Grant award of $418,178 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to provide mechanistic insights into the neurobiological mechanisms by which maternal sensitivity is compromised by postpartum depression. Specifically, the University of Massachusetts (UMass), through its Office of Grant & Contract Administration, will use intersectional viral...
This $221,805 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to examine the effects of maternal immune activation (MIA) on brain and behavioral development in a nonhuman primate model. The research aims to: 1) Evaluate alterations in socioemotional behavior and longitudinally map amygdala development in MIA-exposed nonhuman primates, 2) Examine...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $183,096 to the University of Maryland, Baltimore to study the structural, functional, and neurobehavioral consequences of COVID-19 infection in adolescents. The key objectives are to: 1) Identify morphometric and microstructural brain abnormalities associated with SARS-CoV-2 infection through longitudinal MRI data analysis; 2) Determine if...
This Project Grant award of $682,879, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to address the significant deficiencies in understanding the neural pathogenesis of congenital cytomegalovirus (HCMV) infection in human brain tissues. The award will fund research to: (1) define the transcriptional and cellular disruptions to developing human neural cells caused by HCMV infection, (2)...